Effect of hormone replacement therapy on cardiovascular risk factors in postmenopausal women with diabetes

Diabetes, Obesity and Metabolism

Volumn 6, Issue 1, 2004, Pages 16-22

  Scott, Adrian R ^a,d   Dhindsa, P ^a   Forsyth, J ^b   Mansell, P ^c  

^a UNIVERSITY OF NOTTINGHAM   (United Kingdom)

^b DERBYSHIRE ROYAL INFIRMARY   (United Kingdom)

^c QUEEN S MEDICAL CENTRE   (United Kingdom)

^d WAIKATO HOSPITAL   (New Zealand)

Author keywords

Cardiovascular disease; Diabetes mellitus; Hormone replacement therapy; Oestrogens

Indexed keywords

APOLIPOPROTEIN B; CHOLESTEROL; ESTRADIOL PLUS NORETHISTERONE ACETATE; ESTROGEN; GESTAGEN; HIGH DENSITY LIPOPROTEIN CHOLESTEROL; KLIOFEM; LIPID; LOW DENSITY LIPOPROTEIN CHOLESTEROL; PLACEBO; TRIACYLGLYCEROL;

ADULT; ARTICLE; BLOOD PRESSURE MONITORING; BODY WEIGHT; CARBOHYDRATE METABOLISM; CARDIOVASCULAR DISEASE; CARDIOVASCULAR RISK; CHOLESTEROL BLOOD LEVEL; CLINICAL TRIAL; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; DIABETES MELLITUS; DRUG EFFICACY; FEMALE; FRAGILITY FRACTURE; GLUCOSE BLOOD LEVEL; HORMONE SUBSTITUTION; HUMAN; HYPOTHESIS; INSULIN DEPENDENT DIABETES MELLITUS; LIPID BLOOD LEVEL; MAJOR CLINICAL STUDY; MASTALGIA; NON INSULIN DEPENDENT DIABETES MELLITUS; POSTMENOPAUSE; SCORING SYSTEM; VAGINA BLEEDING;

EID: 0742289445     PISSN: 14628902     EISSN: None     Source Type: Journal    
DOI: 10.1111/j.1463-1326.2004.00294.x     Document Type: Article

References (30)

1. Hunt K. Perceived value of treatment among a group of long-term users of hormone replacement therapy. J R Coll Gen Pract 1998; 38: 388-401.
2. Ditkoff EC, Crary WG, Cristo M et al . Estrogen improves psychological function in asymptomatic postmenopausal women. Obstet Gynecol 1991; 78: 991-995.
3. Lindsey R, Hart DM, Aiken JM et al. Long-term prevention of postmenopausal osteoporosis by oestrogen. Lancet 1976; 1: 1038-1041.
4. Daly E, Roche M, Barlow D et al . Hormone replacement therapy: an analysis of benefits, risks and costs. Br Med Bull 1992; 48: 368-400.
5. Stamfer MJ, Willett WC, Colditz GA et al. A prospective study of postmenopausal estrogen therapy and coronary heart disease. N Engl J Med 1985; 313: 104-1049.
6. Stamfer MJ, Golditz GA. Estrogen replacement therapy and coronary heart disease: a quantitative assessment of epidemiological evidence. Prev Med 1991; 20: 47-63.
7. Stamfer MJ, Colditz GA, Willett WC et al. Postmenopausal estrogen therapy and cardiovascular disease. Ten year follow-up from the nurses' health study. N Engl J Med 1991; 325: 756-762.
8. Kaplan RC, Heckbert SR, Weiss NS. Postmenopausal estrogens and risk of myocardial infarction in diabetic women. Diabetes Care 1998; 21: 1117-1121.
9. Hulley S, Grady D, Bush T et al. Randomised trial of estrogen plus progestin for secondary prevention of coronary heart disease in postmenopausal women. Heart and Estrogen/Progestin Replacement Study (HERS) Research Group. JAMA 1998; 280: 605-613.
10. Grady D, Herrington D, Bittner V et al. Cardiovascular outcomes during 6.8 years of hormone therapy: Heart and Estrogen/Progestin Replacement Study follow-up (HERS II). JAMA 2002; 288: 49-57.
11. Lokkegaard E, Pedersen AT, Heitmann BL et al. Relation between hormone replacement therapy and ischaemic heart disease in women: prospective observational study. BMJ 2003; 326: 426-428.
12. Munk-Jenson N, Ulrich LG, Obel EB et al. Continuous combined and sequential estradiol and norethindrone acetate treatment of postmenopausal women: effect on plasma lipoproteins in two year placebo-controlled trial. Am J Obstet Gynecol 1994; 171: 132-138.
13. Andersson B, Mattson LA, Hahn L et al. Estrogen replacement therapy decreases hyperandrogenicity and improves glucose homeostasis and plasma lipids in postmenopausal women with non-insulin dependent diabetes mellitus. J Clin Endocrinol Metab 1997; 82: 638-643.
14. Friday KE, Dong C, Fontenot RU. Conjugated equine estrogen improves glycaemic control and blood lipids in post-menopausal women with type 2 diabetes. J Clin Endocrinol Metab 2001; 86: 48-52.
15. Manwaring P, Morfis L, Diamond T, Howes LG. The effects of hormone replacement therapy on plasma lipids in type II diabetes. Maturitas 2000; 34: 239-247.
16. Koh KK, Kang MH, Jin DK et al. Vascular effects of estrogen in type II diabetic postmenopausal women. J Am Coll Cardiol 2001; 38: 1409-1415.
17. Brussaard HE, Gevers Leuven JA, Frolich M, Kluft C, Krans HM. Short-term oestrogen replacement therapy improves insulin resistance, lipids and fibrinolysis in postmenopausal women with NIDDM. Diabetologia 1997; 40: 843-849.
18. Sattar N, McKenzie J, MacCuish AC, Jaap AJ. Hormone replacement therapy in Type 2 diabetes mellitus: a cardiovascular perspective. Diabet Med 1998; 15: 631-633.
19. Kannel WB, Hjortlaud MC, McNamara PM et al. Menopause and the risk of cardiovascular disease: the Framingham study. Ann Intern Med 1976; 85: 447-452.
20. Kannel WB, McGee DL. Diabetes and cardiovascular risk factors: Framingham Study. Circulation 1976; 59: 8-13.
21. Garcia MJ, McNamara PM, Gordon T et al. Morbidity and mortality in diabetes in the Framingham population: sixteen year follow-up study. Diabetes 1974; 23: 105-111.
22. Godsland IF, Crook D, Simpson R et al. The effects of different formulations of oral contraceptive agents on lipid and carbohydrate metabolism. N Engl J Med 1990; 323: 1375-1381.
23. Walsh BW, Schiff I, Rosner B, Grenberg L, Ravnikar V, Sacks FM. Effect of postmenopausal estrogen replacement on the concentrations and metabolism of plasma lipoproteins. N Engl J Med 1991; 325: 1196-1204.
24. Nelson HD,HumphreyLL,NygrenP, TeutschSM, AllanJD. Postmenopausal hormone replacement therapy: scientific review. JAMA 2002; 288: 321-333.
25. Womens Health Initiative Investigators. Risks and benefits of estrogen plus progestin in healthy postmenopausal women. JAMA 2002; 288: 321-333.
26. Robinson JG, Folsom AR, Nabulsi AA, Watson R, Brancati FL, Cai J. Can postmenopausal hormone replacement improve plasma lipids in women with diabetes? Diabetes Care 1996; 19: 480-485.
27. Espeland MA, Hogan PE, Fineberg SE, et al. Effect of postmenopausal hormone therapy on glucose and insulin concentrations. Diabetes Care 1998; 21: 1589-1595.
28. Barrett-Conner E, Grady D. Hormone replacement therapy, heart disease, and other considerations. Annu Rev Public Health 1998; 19: 55-72.
29. Hemminki E, McPherson K. Impact of postmenopausal hormone therapy on cardiovascular events and cancer: pooled data from clinical trials. BMJ 1997; 315: 149-153.
30. Matthews KA, Kuller LH, Wing RR, Meilahn EN, Plantinga P. Prior to use of estrogen replacement therapy, are users healthier than nonusers? Am J Epidemiol 1996; 143: 971-978.